MOB3A: A Protein Target for Cancer and Other Diseases (G126308)

Target Name: MOB3A

NCBI ID: G126308

MOB3A

MOB3A: A Protein Target for Cancer and Other Diseases

MOB3A, short for MOB3-containing intercellular adhesion molecule, is a protein that is expressed in various tissues throughout the body. It is a member of the intercellular adhesion molecule (ICAM) family, which is a subgroup of the immunoglobulin superfamily. MOB3A is involved in many different cellular processes in the body, including cell adhesion, migration, and invasion.

One of the most promising aspects of MOB3A is its potential as a drug target. Its involvement in several key cellular processes makes it an attractive target for small molecule inhibitors, which could have a wide range of therapeutic applications.

MOB3A is involved in cell adhesion, which is the process by which cells stick together to form tissues and organs. This is a critical process for many different cell types, including neurons, muscle cells, and epithelial cells. MOB3A plays a key role in this process by helping to regulate the interactions between cells.

MOB3A is also involved in cell migration, which is the process by which cells move from one location to another. This is important for many different types of cells, including cancer cells. MOB3A plays a key role in this process by helping to regulate the movement of cells along the cell surface.

MOB3A is also involved in cell invasion, which is the process by which cells move into the tissue of another cell. This is important for many different types of cancer cells, including melanoma cells. MOB3A plays a key role in this process by helping to regulate the movement of cells through the tissue.

One of the most promising aspects of MOB3A as a drug target is its involvement in cancer. MOB3A is often overexpressed in many types of cancer, which makes it an attractive target for small molecule inhibitors. By inhibiting the activity of MOB3A, researchers hope to reduce the growth and spread of cancer cells.

In addition to its involvement in cancer, MOB3A is also involved in other cellular processes that are important for human health. For example, MOB3A is involved in the development and maintenance of the blood-brain barrier, which is the barrier that separates the brain from the rest of the body. This is important for maintaining the health and function of the brain.

MOB3A is also involved in the regulation of inflammation, which is a critical process for maintaining human health. It is involved in the production and regulation of many different types of immune cells, including natural killer cells and T cells. This is important for protecting the body against infection and disease.

In conclusion, MOB3A is a protein that is involved in a wide range of cellular processes in the body. Its involvement in cell adhesion, migration, and invasion makes it an attractive target for small molecule inhibitors. In addition, MOB3A is involved in the regulation of cancer growth and the immune system, which makes it an important target for drug development. Further research is needed to fully understand the role of MOB3A in these processes and to develop effective treatments.

Protein Name: MOB Kinase Activator 3A

Functions: May regulate the activity of kinases

The "MOB3A Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MOB3A comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets